← Apex Wire
Insider activity — ASPEAspen Neuroscience, Inc.

4 Form 4 filings for ASPE between 2026-11-02 and 2026-11-02, from 4 filers. 4 discretionary (0 sales, 2 purchases). 2 of 4 carry a dollar total (2 stated, 0 computed as shares × price), summing to $37,999,995; a multi-transaction filing without a stated total contributes only its largest transaction, so the sum is a floor and the true figure is higher. Prices ran $15 to $15.

Filings 4 Filers 4 Discretionary 4 Routine 0 Structured 4/4

Filers
▸ARCH Venture Partners X, L.P.10% Owner 2026-11-02 · purchased (open market) 1,200,000 @ $15.00 for $19,999,995 TOTAL BOUGHT ≥ $19,999,9951 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 purchased (open market) 1,200,000 $15.00 $19,999,995 12 RECEIPT ↗
▸ARCH Venture Partners XIV, LLC10% Owner 2026-11-02 · purchased (open market) 1,200,000 @ $15.00 for $18,000,000 TOTAL BOUGHT ≥ $18,000,0001 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 purchased (open market) 1,200,000 $15.00 $18,000,000 1 RECEIPT ↗
▸Spaventa AndrewDirector 2026-11-02 · converted (derivative) 180,221 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 converted (derivative) 180,221 — — 2 RECEIPT ↗
▸Hasnain FaheemExecutive Chair 2026-11-02 · converted (derivative) 14,913 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 converted (derivative) 14,913 — — 3 RECEIPT ↗

4 filers · 4 filings · disclosed filing totals sum to $37,999,995 (2/4 state one, 0 computed; totals are proceeds with a floor, never profit — a Form 4 states what was traded, not what it cost the filer)

Elsewhere